CA 19-9 and carcinoembryonic antigen in pancreatic cancer diagnosis [PDF]
Cancer, 1986 CA 19-9 (Centocor, Malvern, PA) and carcinoembryonic antigen (CEA), two recently developed immunoradiometric assays utilizing monoclonal antibodies, were evaluated in the sera of 139 subjects in order to assay their individual and combined value in pancreatic cancer diagnosis and to assess the influence of jaundice.
DEL FAVERO G. +9 more
openaire +3 more sources
Prognostic Value of Carcinoembryonic Antigen (CEA) and Carbohydrate Antigen 19-9 (CA 19-9) in Gallbladder Cancer; 65 IU/mL of CA 19-9 Is the New Cut-Off Value for Prognosis [PDF]
Cancers, 2021 Due to the lack of appropriate tumor markers with optimal cut-off values to predict the prognosis of gallbladder cancer (GBC), this study aimed to demonstrate the relationship between prognosis and the levels of carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA 19-9), and to determine optimal thresholds.
Myongjin Kim +6 more
openaire +2 more sources
Relationship between serum calcium and CA 19-9 levels in colorectal cancer [PDF]
, 2004 AIM: To examine the calcium metabolism of colorectal cancer (CRC) in patients with colorectal cancer and control patients. METHODS: Seventy newly diagnosed CRC patients were included.
Fuszek, Péter +8 more
core +1 more source
Pancreatic Tuberculosis with Markedly Elevated CA 19-9 Levels: A Diagnostic Pitfall
Oman Medical Journal, 2016 Despite the high prevalence of tuberculosis (TB) in developing countries, isolated pancreatic TB is rare and is usually seen in immunocompromised patients.
Manveen Kaur +3 more
doaj +1 more source
The Pan African Medical Journal, 2020 Ovarian cancer is the seventh most commonly diagnosed cancer among women in the world and epithelial ovarian cancer is the most predominant pathologic subtype.
Francesk Mulita +4 more
doaj +1 more source
Elevated Carbohydrate Antigen 19-9 (CA 19-9) in Patients with Echinococcus Infection [PDF]
Clinical Chemistry and Laboratory Medicine, 2001 The carbohydrate antigen 19-9 (CA 19-9), a determinant (sialylated lacto-N-fucopentaose 119) of a circulating oligosaccharide antigen, is a frequently used tumor marker. Echinococcus spp. infects humans throughout the world and may be able to synthesize closely related molecules which could interfere with the measurement and interpretation of CA 19-9 ...
Pfister, M +4 more
openaire +4 more sources
First-line erlotinib and fixed dose-rate gemcitabine for advanced pancreatic cancer [PDF]
, 2013 AIM: To investigate activity, toxicity, and prognostic factors for survival of erlotinib and fixed dose-rate gemcitabine (FDR-Gem) in advanced pancreatic cancer.
Bria, E. +9 more
core +1 more source
Cancer Antigens (CEA and CA 19-9) as Markers of Advanced Stage of Colorectal Carcinoma [PDF]
Medical Archives, 2013 CEA and CA 19-9 are the most common tumor associated antigens used in the staging of patients with rectal cancer and other parts of the colon.of this study was to evaluate the value of CEA and CA 19-9 in serum of patients with colon cancer and prove its place in the diagnostic staging.The study was retrospective-prospective performed at the ...
Vukobrat-Bijedic, Zora +6 more
openaire +2 more sources
Serum carcinoembryonic antigen tends to decrease in poorly-differentiated colorectal cancer
Universa Medicina, 2015 BACKGROUND Carcinoembryonic antigen (CEA) and carbohydrate antigen (CA) 19-9 are tumor markers for colorectal cancer (CRC), both having prognostic value.
Ester Morina Silalahi +2 more
doaj +1 more source
Applied Bionics and Biomechanics, 2022 Objective. This study aimed to determine if variations in the expression profiles of CA 19-9 and carcinoembryonic antigen (CEA) within the reference range could serve as possible biomarkers for postoperative CRC recurrence. Method.
Lujia Wang +4 more
doaj +1 more source